Novozymes M&A Chief Videbaek Makes Mark With Bio-Products Deal

Thomas Videbaek made his mark on strategy as chief dealmaker at Novozymes A/S with an $80 million purchase of a Canadian supplier of paper and textile enzymes.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.